16-02-2023, 19:44

Arbutus to Report Fourth Quarter and Year End 2022

WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage
Globe Newswire16-02-2023, 19:44
27-01-2023, 19:32

Arbutus Announces Resignation of Board Member

WARMINSTER, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage
Globe Newswire27-01-2023, 19:32